Malcolm Brenner is Director at Allovir, Inc. (ALVR). They have made 5 open-market trades across 1 company since 2021, most recently 2024-06-06.
CIK 0001818068
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ALVR | 100,197 | $983K |
Shares reported on the most recent Form 4, priced at the 2024-06-07 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ALVR | SELL | 2021-03-04 | 2021-03-08 | $33.50 | $6.4M | -14.3% | -22.5% | -20.4% |
| ALVR | SELL | 2021-03-01 | 2021-03-03 | $38.18 | $3.3M | -21.8% | -32.2% | -38.0% |
| ALVR | SELL | 2021-02-19 | 2021-02-23 | $41.56 | $2.5M | -20.8% | -43.3% | -44.2% |
| ALVR | SELL | 2021-02-18 | 2021-02-19 | $40.84 | $512K | -10.8% | -38.5% | -46.6% |
| ALVR | SELL | 2021-02-16 | 2021-02-18 | $41.23 | $583K | -8.6% | -38.2% | -49.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.